Zheng H, Lin D, Hong B, Yao X
Hua Xi Yi Ke Da Xue Xue Bao. 1992 Sep;23(3):276-9.
DNA ploidy, S% and proliferative index (PI) of carcinomatous cell were evaluated with FCM in 41 patients with laryngeal primary squamous cell carcinomas which were operated on in our department during the period between Jan. 1979 to Oct. 1987. The results showed that DNA aneuploidy was identified in 65.85% of the cases (27/41) and patients with aneuploid carcinomas had higher S% (mean +/- standard: 23.22 +/- 9.57%), higher PI (mean +/- standard: 37.59 +/- 9.57%) and higher rate of relapse and/or metastasis than those with diploid tumours (55.55% vs 11.77%, P < 0.025). Patients with aneuploid carcinomas also correlated with an unfavorable prognosis compared with those with diploid tumors. Cases with aneuploid and diploid carcinomas had 66.11% and 92.86% respectively for two years postoperation survival rate; 46.74% and 92.86% respectively for five years postoperation survival rate (Log-rank test: chi 2 = 5.96, P < 0.025). We conclude that nuclear DNA measurement with flow cytometry is of important significance in estimating prognosis and guiding treatment for laryngeal squamous cell carcinomas.
1979年1月至1987年10月期间,对在我科接受手术的41例喉原发性鳞状细胞癌患者,采用流式细胞术(FCM)评估癌细胞的DNA倍体、S%和增殖指数(PI)。结果显示,65.85%的病例(27/41)检测到DNA非整倍体,非整倍体癌患者的S%更高(均值±标准差:23.22±9.57%),PI更高(均值±标准差:37.59±9.57%),复发和/或转移率高于二倍体肿瘤患者(55.55%对11.77%,P<0.025)。与二倍体肿瘤患者相比,非整倍体癌患者的预后也较差。非整倍体癌和二倍体癌患者术后两年生存率分别为66.11%和92.86%;术后五年生存率分别为46.74%和92.86%(对数秩检验:χ2=5.96,P<0.025)。我们得出结论,流式细胞术检测核DNA对评估喉鳞状细胞癌的预后和指导治疗具有重要意义。